Stereocontrolled preparation of a nonpeptidal (-)-spirobicyclic NK-1 receptor antagonist.

J Org Chem

Department of Process Research, Merck Sharp & Dohme Research Laboratories, Merck & Co., Inc., Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU, UK.

Published: February 2002

The synthesis of a spirobicyclic NK-1 receptor (Substance-P) antagonist 1 antipode is described. Retrosynthetic analysis reveals an allylic halide A bearing the cyclopropoxy-substituted aryl group and a 2-phenyl-3-piperidone B. The stereochemistry in the spirobicyclic system bearing three chiral centers is initially set via a highly diastereoselective zinc-mediated coupling of the allylic bromide 23 to the optically active ketopiperidine 3. The remaining benzylic asymmetric center is set by a diastereoselective hydroboration followed by cyclization to the spirobicyclic system.

Download full-text PDF

Source
http://dx.doi.org/10.1021/jo0157472DOI Listing

Publication Analysis

Top Keywords

nk-1 receptor
8
spirobicyclic system
8
stereocontrolled preparation
4
preparation nonpeptidal
4
nonpeptidal --spirobicyclic
4
--spirobicyclic nk-1
4
receptor antagonist
4
antagonist synthesis
4
synthesis spirobicyclic
4
spirobicyclic nk-1
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!